{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:47:30Z","timestamp":1790254050469,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust, UK","doi-asserted-by":"publisher","award":["104252"],"award-info":[{"award-number":["104252"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council (MRC) UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012822","name":"Danish Ministry of Foreign Affairs, Flanders Department of Foreign Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012822","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Federal Ministry of Education and Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ijpharm.2019.04.040","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T01:51:05Z","timestamp":1555293065000},"page":"207-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES"],"prefix":"10.1016","volume":"564","author":[{"given":"John W.","family":"McBride","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Karl","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin E.","family":"Offord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky L.","family":"Kett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brid","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-6053","authenticated-orcid":false,"given":"Peter","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.ijpharm.2019.04.040_b0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1471-0528.12843","article-title":"Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies","volume":"121","author":"Abdool Karim","year":"2014","journal-title":"BJOG"},{"issue":"Suppl.","key":"10.1016\/j.ijpharm.2019.04.040_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1471-0528.12842","article-title":"The need for multipurpose prevention technologies in sub-Saharan Africa","volume":"121","author":"Abdool Karim","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ijpharm.2019.04.040_b0015","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"Suppl.","key":"10.1016\/j.ijpharm.2019.04.040_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/1471-0528.12851","article-title":"Making the case for multipurpose prevention technologies: the socio-epidemiological rationale","volume":"121","author":"Boonstra","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ijpharm.2019.04.040_b0025","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.antiviral.2013.09.019","article-title":"Lessons from reproductive health to inform multipurpose prevention technologies: don\u2019t reinvent the wheel","volume":"100","author":"Brady","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2015.10.011","article-title":"A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris","volume":"119","author":"Cerini","year":"2016","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0035","article-title":"Phase 1 safety, pharmacokinetics, and pharmacodynamics of dapivirine and maraviroc vaginal rings","volume":"1","author":"Chen","year":"2015","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0040","first-page":"1","article-title":"Phase 2a safety, pharmacokinetics, and acceptability of dapivirine vaginal rings in US postmenopausal women","volume":"15213","author":"Chen","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.tim.2015.02.006","article-title":"Multipurpose prevention technologies: the future of HIV and STI protection","volume":"23","author":"Fern\u00e1ndez-Romero","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ejps.2012.12.002","article-title":"A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action","volume":"48","author":"Fetherston","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jac\/dks415","article-title":"Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220","volume":"68","author":"Fetherston","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0060","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.antiviral.2013.09.030","article-title":"Multipurpose prevention technologies: Products in development","volume":"100","author":"Friend","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jana.2017.06.003","article-title":"Multipurpose prevention technologies: a global sexual and reproductive health priority","volume":"29","author":"Guilamo-Ramos","year":"2018","journal-title":"J. Assoc. Nurses AIDS Care"},{"key":"10.1016\/j.ijpharm.2019.04.040_b0070","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.04954-14","article-title":"The sheep as a model for preclinical safety and pharmacokinetic evaluations of candidate microbicides","author":"Holt","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejps.2009.11.007","article-title":"Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir","volume":"39","author":"Johnson","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0168-3659(03)00178-0","article-title":"Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings","volume":"90","author":"Malcolm","year":"2003","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2019.04.040_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.addr.2016.01.015","article-title":"Microbicide vaginal rings: technological challenges and clinical development","volume":"103","author":"Malcolm","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0090","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/jac\/dkt506","article-title":"Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral application","volume":"69","author":"Malcolm","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0095","unstructured":"Mallolas, J., n.d. Darunavir Stands Up as Preferred HIV Protease Inhibitor. AIDS Rev. 19, 105\u2013112."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.02.003","article-title":"Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES","author":"McBride","year":"2019","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2019.04.040_b0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/AAC.00965-17","article-title":"Pharmacokinetics of the protein microbicide 5P12-RANTES in sheep following single-dose vaginal gel administration","volume":"61","author":"McBride","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2019.01.026","article-title":"Mechanical testing methods for drug-releasing vaginal rings","volume":"559","author":"McCoy","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0115","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/AAC.00547-13","article-title":"Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model","volume":"57","author":"Moss","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0120","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1128\/AAC.00391-16","article-title":"Combination pod-intravaginal ring delivers antiretroviral agents for HIV prophylaxis: pharmacokinetic evaluation in an ovine model","volume":"60","author":"Moss","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.08.051","article-title":"Impact of ring size and drug loading on the pharmacokinetics of a combination dapivirine-darunavir vaginal ring in cynomolgus macaques","volume":"550","author":"Murphy","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0130","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1093\/jac\/dku160","article-title":"Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir","volume":"69","author":"Murphy","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0135","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/QAD.0000000000000280","article-title":"A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women","volume":"28","author":"Nel","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.ijpharm.2019.04.040_b0140","first-page":"1000355","article-title":"Pharmacokinetics and safety assessment of Anti-HIV dapivirine vaginal microbicide rings with multiple dosing","volume":"05","author":"Nel","year":"2014","journal-title":"J. AIDS Clin. Res."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0145","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/DDDT.S133170","article-title":"Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes","volume":"11","author":"Notario-P\u00e9rez","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0150","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpba.2016.03.023","article-title":"Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence","volume":"125","author":"Spence","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fvets.2014.00019","article-title":"Characterization of the vaginal microbiota of ewes and cows reveals a unique microbiota with low levels of lactobacilli and near-neutral pH","volume":"1","author":"Swartz","year":"2014","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0165","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/IJWH.S34030","article-title":"Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies","volume":"5","author":"Thurman","year":"2013","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.ijpharm.2019.04.040_b0170","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/cpt.1212","article-title":"Current state of microbicide development","volume":"104","author":"Traore","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2019.04.040_b0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2015.06.018","article-title":"A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy","volume":"213","author":"Ugaonkar","year":"2015","journal-title":"J. Controlled Release"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319303023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319303023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:39:11Z","timestamp":1759916351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517319303023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":35,"alternative-id":["S0378517319303023"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.04.040","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}